CanadaBis Capital Inc. and 1926360 Alberta Ltd. doing business as Stigma Pharmaceuticals (‘Stigma'), announced that the parties have entered into an amalgamation agreement dated October 1, 2018 pursuant to which a subsidiary of CanadaBis will amalgamate (the ‘Amalgamation') with Stigma. Following is a description of the proposed management of the Resulting Issuer. Travis McIntyre will be the President, CEO and a Director of the Resulting Issuer and Travis is the proud founder and president of Stigma Group.

Travis brings with him a strong background in business management primarily in the oil and gas/civil construction sectors. He presently serves as president and CEO of both SS Pipelines. Gregory Smith will be the Chief Financial Officer and a Director of the Resulting Issuer and is a Chartered Professional Accountant and President of Oakridge Financial Management Inc. Barbara O'Neill will be the Corporate Secretary and a Director of the Resulting Issuer and has been Corporate Secretary for a number of TSX and TSX Venture Corporations primarily in the mining industry, both nationally and internationally, for the last 25 years.

She is currently Corporate Secretary of Jade Leader Corp. and Canex Metals Inc. Douglas A. Dafoe will be a Director of the Resulting Issuer and has more than 30 years of industry experience in financial and operating positions of increasing responsibility. Mr. Dafoe is currently the President & Chief Executive Officer of Ember Resources Inc. Alex Michaud will be a Director of the Resulting Issuer and is currently the Managing Partner with Runway Developments.